Business
Statement regarding media speculation
Spire Healthcare Group plc has confirmed that Bridgepoint Advisers Limited and Triton Investment Advisers LLP are among parties in discussions regarding a strategic review, though these discussions are preliminary and no firm offer has been made. Both Bridgepoint and Triton are required to announce a firm intention to make an offer or state they do not intend to by 5:00 p.m. on February 21, 2026, unless an extension is granted by the Panel on Takeovers and Mergers. Disclaimer*
About this update from Spire Healthcare Group Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION\nTHIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE \"CODE\") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE\nFOR IMMEDIATE RELEASE\n24 January 2026\nSpire Healthcare Group plc (\"Spire Healthcare\", the \"Company\")\nStatement regarding media speculation\nFollowing recent media speculation, the Board of Spire Healthcare confirms that Bridgepoint Advisers Limited (\"Bridgepoint\"), and Triton Investment Advisers LLP (\"Triton\"), are amongst the parties in discussions with the Company in the context of the strategic review announced on 18 September 2025. These discussions remain at a preliminary stage.\nThere can be no certainty that any offer will be made for the Company nor as to the terms of any offer, if made.\nThe Board will make a further announcement on this matter in due course as appropriate.\nIn accordance with Rule 2.6(a) of the Code, Bridgepoint and Triton are each required, by not later than 5.00 p.m. on 21 February 2026, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that they do not intend to make an offer for the Company, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel on Takeovers and Mergers in accordance with Rule 2.6(c) of the Code.\nCode dispensations\nAs previously announced, the Takeover Panel Executive has granted a dispensation from the requirements of Rules 2.4(a) and 2.4(b) of the Code such that Spire Healthcare is not required to identify in this announcement any potential offeror with which the Company is in talks, or from which an approach has been received, unless that potential offeror is specifically identified in any rumour or speculation.\nThe person responsible for making this announcement is: Mantraraj Budhdev, Group General Counsel and Company Secretary\nENQUIRIES:\nFor further information pleas...